pCOCK CM-R05
(Plasmid
#46568)
-
PurposeMammalian expression plasmid with EGFP expressed from synthetic promoter (random mutagenesis of CMVwt 3' end).
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 46568 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepEF5-FRT-V5-DEST
-
Backbone manufacturerLife Technologies
- Backbone size w/o insert (bp) 7528
- Total vector size (bp) 6182
-
Modifications to backbone1. EF1alpha promoter removed (so attR Gateway sites can be used to clone in synthetic promoters) 2. IVS-EGFP cassette inserted between attR Gateway cassette and BGH polyA 3. Synthetic promoters flanked by attL in pDONR221 (Life Technologies) vectors were used to recombine promoters into the vector resulting from modifications 1 and 2 above.
-
Vector typeMammalian Expression, Synthetic Biology
-
Selectable markersHygromycin ; No ATG until recombines into FRT site in target cell genome
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)XL1 Blue
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCMV mutant promoter
-
SpeciesCytomegalovirus viral promoter
-
Insert Size (bp)587
-
MutationMutant version of CMV promoter (refer to Table 1 for sequence and strength information)
-
GenBank ID
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCOCK CM-R05 was a gift from Clifford Wang (Addgene plasmid # 46568 ; http://n2t.net/addgene:46568 ; RRID:Addgene_46568) -
For your References section:
Modulating ectopic gene expression levels by using retroviral vectors equipped with synthetic promoters. Ferreira JP, Peacock RW, Lawhorn IE, Wang CL. Syst Synth Biol. 2011 Dec;5(3-4):131-8. doi: 10.1007/s11693-011-9089-0. Epub 2011 Nov 20. 10.1007/s11693-011-9089-0 PubMed 23205156